AlphaVax Email Format

Biotechnology ResearchNorth Carolina, United States2-10 Employees

AlphaVax is a biotechnology research company focused on advancing vaccine and immunology platforms, with a pipeline that targets pandemic influenza and cytomegalovirus (CMV) and includes grant- and collaborator-supported programs in HIV, prostate and breast cancer, as well as several biodefense vaccines. Early human trials of the alphavaccine vector have demonstrated safety and immunological activity, producing robust and balanced antibody and T-cell responses after years of pre-clinical work. The firm serves researchers and partners in need of vaccine candidates and immunotherapy programs, offering a platform and programs that address infectious diseases and cancer-related indications. Based in Lake Park, North Carolina, AlphaVax operates in the biotechnology research industry with a relatively small team focused on developing and validating its vaccine and immune-platform approaches.

Sign up for free to view info

Company overview Employee directory